Regional Trials Network Victoria Newsletter, April 2020

COVID-19: Viral Effect on Clinical Trials

The onset of the COVID-19 virus has simultaneously affected each country and each industry and is challenging us all to seek alternative and innovative ways to continue business-as-usual activities.

Clinical trials remain an essential component of Oncology patient care and each site is proactively addressing how to support trial activity under these new and unprecedented conditions.

  • Sites have been collaborating with each other to determine how to respond to:
  • Clinical Trial Operational Considerations that includes options for Sponsor remote monitoring
  • Risk Reduction Initiatives for patients that include Telehealth and Teletrial options for patient visits
  • Workforce Considerations to support ongoing trials and the best use of shared resourcing

Sites are also assessing their resources to support the implementation and ongoing management of COVID-19 clinical trials.